CNTB News and Press, Connect Biopharma Holdings Limited From 03/26/23

2023-03-26 23:52:00 ET Summary Highlightll Pharma out-licensed rights to its novel oral, brain-penetrating, dual inhibitor to New Haven’s Biohaven in a deal worth up to $970 million. F-star, a Cambridge, UK biopharma, out-licensed global rights for a novel next-gen immuno-o...

2023-03-21 10:03:51 ET Gainers: ImmunityBio ( IBRX ) +21% . NuCana ( NCNA ) +16% . Seres Therapeutics ( MCRB ) +14% . SCYNEXIS ( SCYX ) +13% . Corbus Pharmaceuticals ( CRBP ) +12% . Losers: Altimmune ( ALT ) ...

2023-03-21 08:20:25 ET Altimmune ( ALT ) -37% announces positive results from week 24 interim analysis of Pemvidutide MOMENTUM phase 2 obesity trial and 12-Week phase 1b type 2 diabetes safety trial. First Majestic Silver ( AG ) -14% suspends mining at Jerrit...

2023-03-20 13:16:55 ET Connect Biopharma ( NASDAQ: CNTB ) jumped ~19% most in seven months on Monday after presenting pivotal data for its lead candidate CBP-201 in moderate-to-severe atopic dermatitis (AD) at the American Academy of Dermatology Annual Meeting over the wee...

2023-03-20 13:07:07 ET Gainers: Loyalty Ventures ( LYLT ) +97% . Ambipar Emergency ( AMBI ) +73% . Lifecore Biomedical ( LFCR ) +60% . InMed Pharmaceuticals ( INM ) +43% . New York Community Bancorp ( NYCB ) +32% . Harbor Cus...

2023-03-20 10:29:09 ET Gainers: Lifecore Biomedical ( LFCR ) +41% . Connect Biopharma ( CNTB ) +27% . InMed Pharmaceuticals ( INM ) +21% . ReShape Lifesciences ( RSLS ) +21% . Bellerophon Therapeutics ( BLPH ) +15% . Losers...

2023-03-20 08:46:36 ET InMed Pharmaceuticals ( INM ) +29% . New York Community Bancorp ( NYCB ) +27% shines with 30% gain on multiple analyst upgrades amid Signature deal. PacWest Bancorp ( PACW ) +20% . ReShape Lifesciences  ( RSLS ) ...

2023-03-19 11:26:12 ET Stock Market Outlook This Week: March 20th – March 24th Whether you’re trading penny stocks or searching for the best high-dividend stocks to invest in for 2023, knowing what to expect in the week ahead could help you understand how to approa...

Late-Breaking Abstract and Oral Presentation at American Academy of Dermatology Annual Meeting Stage 1 of ongoing 52-week China pivotal AD trial met primary and secondary endpoints No efficacy plateau at Week 16 Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect ...

ePoster and Oral Presentation at American Academy of Dermatology Annual Meeting Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a global clinical-stage biopharmaceutical company developing T cell-driven therapies to treat inflammatory diseases, ...